FBS vs. Human Serum — Complete Selection Guide
The choice between fetal bovine serum (FBS) and human serum is application-driven. This guide covers the key differences in composition, performance and regulatory compliance — with specific recommendations for cell culture, immunology, ATMP manufacturing and IVD development.
Key Differences at a Glance
| Parameter | Fötales Rinderserum (FBS) | Human Serum |
|---|---|---|
| Source | Bovine fetal blood — USA, Australia, NZ, South America | Adult human donors — EU and US donor centres |
| IgG content | Very low (0.1–1 mg/mL standard; <50 µg/mL Ultra-Low IgG) | High (7–16 mg/mL normal range) — unless IgG-depleted |
| Growth factors | High (PDGF, EGF, IGF-1, FGF) — especially OTC human serum has higher PDGF | OTC human serum: highest natural growth factor content |
| Xeno-free status | Animal-derived — not xeno-free | Human-derived — xeno-free for human cell applications |
| Regulatory status | TSE/BSE documentation required. GMP pathway with origin documentation | Donor screening per EU blood directive. IVDR documentation available |
| Cost (typical) | Lower — standard cost baseline | 3–8× higher per litre |
| Batch variation | Lot qualification recommended | Pooled lots — lower donor-to-donor variation |
| Processing (SeamlessBio) | Germany (Passau) | Germany (Passau) |
Application-Specific Recommendation
| Anwendung | Recommended | Reason |
|---|---|---|
| CHO, HEK293, Vero, MDCK — routine culture | FBS-Standard | Cost-effective, well-validated, no xeno-free requirement |
| Hybridoma — mAb production | FBS, hitzeinaktiviert | Complement inactivation; low IgG for clean antibody purification |
| ES/iPSC maintenance | FBS ES Cell Pre-Tested or Human Serum OTC | Application-specific lot qualification critical |
| Naive hPSC culture | NaivaCore + FBS ES or Human Serum | HENSM protocol requires specific serum supplement |
| PBMC isolation & culture | Human Serum AB or Human Serum Male | Xeno-free; no HLA alloantibodies for immunological assays |
| CAR-T T-cell expansion | Menschliches Serum, OTC, Typ AB, männlich | Maximum growth factors + AB compatibility + HLA alloantibody-free |
| MSC expansion (research) | FBS Standard or Human Platelet Lysate | FBS for research; hPL preferred for GMP-adjacent |
| MSC expansion (GMP) | Lysat aus menschlichen Blutplättchen (hPL) | Xeno-free, GMP-compatible, 3–5× higher MSC proliferation |
| ATMP manufacturing | Human Serum Cell Culture Grade or hPL | Xeno-free ancillary material required for regulatory submission |
| IVD calibrator matrix | Human Serum Standard or Delipidated | Physiological human matrix; IVDR documentation available |
| Immunoassay blocking | FBS Low Endotoxin or Human Serum Standard | Depends on assay antibody species; match serum to antibody origin |
| ELISA, cytokine assays | Human-Serum-Standard | Human matrix eliminates xenogenic protein interference |
When to Switch from FBS to Human Serum
Xeno-Free Requirement
ATMP and cell therapy manufacturing under IVDR or GMP regulations increasingly requires xeno-free ancillary materials. Human serum or hPL replaces FBS with a regulatory-compliant, human-derived alternative.
Human Primary Cell Performance
Some human primary cells — particularly haematopoietic cells, T-cells and endothelial cells — show significantly better growth, viability and function in human serum versus FBS due to physiological compatibility.
Immunological Assay Interference
Bovine IgG in FBS can cross-react with anti-human secondary antibodies in ELISAs and western blots. Human serum Ultra-Low IgG or FBS Ultra-Low IgG eliminates this interference.
T-Cell & Immunology Assays
For MLR, ELISPOT and antigen-specific T-cell assays, human serum male (HLA alloantibody-free) eliminates pregnancy-induced antibody interference that can suppress antigen-specific responses.
CAR-T Manufacturing
Industry standard for CAR-T T-cell expansion is 5% human AB serum — universal blood type compatibility and xeno-free status. Human OTC AB Male is the premium format combining growth factors, AB type and HLA alloantibody-free status.
IVD Calibrator Development
IVD calibrators require human serum matrix to accurately reflect patient sample composition. Human serum with IVDR documentation is the only correct matrix for immunoassay calibrators designed for human diagnostic use.
Frequently Asked Questions
When should I switch from FBS to human serum?
Switch when: working with human primary cells requiring physiological matrix, application requires xeno-free documentation (ATMP), running T-cell assays where bovine IgG causes background, CAR-T or PBMC culture requiring human AB serum, or regulatory submission requires xeno-free ancillary material justification.
Can human serum replace FBS at the same concentration?
For most human primary cells — yes, 5–10% direct replacement. A qualification step is always recommended. Human OTC serum has higher PDGF, EGF and TGF-β than standard plasma-derived FBS, so growth kinetics may differ.
Is human serum more expensive than FBS?
Yes — typically 3–8× higher per litre. The switch is justified when xeno-free documentation is required or when cell performance is demonstrably better in human serum for your specific application.
Request Samples of Both — Compare Directly
Free test samples of FBS and human serum. No minimum order. Lot reservation without prepayment. 48-hour quote.
English 
Deutsch